NCT07270978 Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS Status RECRUITING Phase PHASE1
NCT07238686 Venetoclax-containing Therapy Combined With Microtransplant for Intermediate-risk and Higher MDS Status RECRUITING Phase PHASE2
NCT07216443 Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Status RECRUITING Phase PHASE2
NCT07183878 Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study) Status RECRUITING Phase NA
NCT07102849 Molecular and Clinical Analysis of Bone Marrow Failure: A Secondary Research Study Status ENROLLING_BY_INVITATION Phase N/A
NCT07075406 A Study to Evaluate Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Patients With Lower-Risk Myelodysplastic Syndromes Treated With Luspatercept Status COMPLETED Phase N/A
NCT07073690 Treatment Patterns and Outcomes in Patients With Lower-risk Myelodysplastic Syndromes Treated With Luspatercept in China Status COMPLETED Phase N/A
NCT07071155 Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia Status RECRUITING Phase EARLY_PHASE1
NCT07044544 Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies Status RECRUITING Phase PHASE1
NCT07019155 Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants Status RECRUITING Phase N/A
NCT06999954 Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform Status RECRUITING Phase N/A
NCT06956755 Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia Status RECRUITING Phase N/A
NCT06923488 Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory Myelodysplastic Syndromes Status RECRUITING Phase PHASE1/PHASE2
NCT06918834 Efficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome Patients Status RECRUITING Phase PHASE2
NCT06904482 Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood Status RECRUITING Phase PHASE2
NCT06851065 A Study to Evaluate Luspatercept Treatment Patterns and Outcomes in Erythropoiesis-Stimulating Agents-Naïve Patients With Lower-Risk Myelodysplastic Syndromes in the United States Status COMPLETED Phase N/A
NCT06847867 A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome Status RECRUITING Phase PHASE2
NCT06802315 Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS) Status RECRUITING Phase PHASE2